Suppr超能文献

PDL1 塑造经典霍奇金淋巴瘤微环境而不诱导 T 细胞耗竭。

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion.

机构信息

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ; Barts NHS Trust, St Bartholomew's Hospital, West Smithfield, London.

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ.

出版信息

Haematologica. 2023 Apr 1;108(4):1068-1082. doi: 10.3324/haematol.2022.280014.

Abstract

Classical Hodgkin lymphoma (CHL) is unusually sensitive to PD1 inhibition and PDL1 is highly expressed on CHL cells and in the tumor microenvironment. This could be interpreted as evidence of exhaustion, but paradoxically, PD1+ lymphocyte infiltration does not predict response to PD1 inhibitors and no increase in cytotoxic markers is seen after PD1 therapy as might be expected with reversal of exhaustion. In contrast to PD1, elevated PDL1 does predict response to PD1 inhibitors and recent data associate both retained CHL MHC-II expression and increased T helper (TH) T-cell receptor diversity with response, suggesting a connection to the TH compartment. We performed a phenotypic, spatial and functional assessment of T-cell exhaustion in CHL and found co-expression of an exhaustion marker and lower PD1 expression in CHL than in reactive nodes whereas the proliferative and cytokine production capacity were similar in CHL and the reactive nodes. We found no correlation between PDL1 expression and exhaustion signatures. Instead, we identified a strong association between PDL1 expression and CHL MHC-II expression, TH recruitment, and enrichment of TH1 regulatory cells. These data suggest that a dominant effect of PDL1 expression in CHL may be TH engagement and promotion of a regulatory microenvironment rather than maintenance of exhaustion.

摘要

经典型霍奇金淋巴瘤(CHL)对 PD1 抑制异常敏感,且 PDL1 在 CHL 细胞和肿瘤微环境中高度表达。这可以解释为衰竭的证据,但矛盾的是,PD1+淋巴细胞浸润并不能预测 PD1 抑制剂的反应,并且在 PD1 治疗后不会像预期的那样看到细胞毒性标志物增加,这可能与衰竭的逆转有关。与 PD1 相反,升高的 PDL1 确实可以预测 PD1 抑制剂的反应,最近的数据将保留的 CHL MHC-II 表达和增加的辅助性 T(TH)T 细胞受体多样性与反应联系起来,提示与 TH 区室有关。我们对 CHL 中的 T 细胞衰竭进行了表型、空间和功能评估,发现衰竭标志物的共表达和 CHL 中 PD1 表达低于反应性淋巴结,而 CHL 和反应性淋巴结中的增殖和细胞因子产生能力相似。我们没有发现 PDL1 表达与衰竭特征之间的相关性。相反,我们发现 PDL1 表达与 CHL MHC-II 表达、TH 募集以及 TH1 调节性细胞的富集之间存在很强的关联。这些数据表明,CHL 中 PDL1 表达的主要作用可能是 TH 参与和促进调节性微环境,而不是维持衰竭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3987/10071123/0580bf2080ce/1081068.fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验